2019 annual financial data
Ernexa Therapeutics 2019 Operating cash flow margin
Direct answer
Operating cash flow margin was 13.85%.
Operating income was -1,212,000 USD and net income was -2,047,000 USD.
Operating cash flow was 2,744,000 USD.
Get free Ernexa Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 19,806,000 USD
- Operating income
- -1,212,000 USD
- Net income
- -2,047,000 USD
- Operating cash flow
- 2,744,000 USD